There is a strong association between endothelial dysfunction and CVD [4], as exemplified by concurrent decreased formation and/or bioactivity of the vasodilator nitric oxide and increased levels and/or activity of the endothelial-derived vasoconstrictor endothelin-1 (ET-1) [4]. The gene discussed is EDN1; the disease is endothelial dysfunction.